DGXQuest Diagnostics
$255.60+47% 1Y
$255.60
$171.9552 weeks$255.60
Latest close: a new 52-week highNov 6, 2026what changed →
The business
How DGX's business earns
Quest Diagnostics earns 11% on the capital it employs against an estimated 9.0% cost of capital.
11%
Return on invested capital · cost of capital 9.0% · 2.0 points above the estimated cost of capital
- Operating margin
- 15%
Operating margin · Diagnostics & Research median 7.1% · 12 months to Sep 30, 2026
- Cash conversion
- 1.47×
Cash conversion · 1.61× a year ago · operating cash flow divided by operating profit after tax
- Share count, year on year
- −0.88%
Share count, year on year · within 1% of a year ago
Operating margin by fiscal year
| Year | Operating margin |
|---|---|
| FY2020 | 21% |
| FY2021 | 22% |
| FY2022 | 14% |
| FY2023 | 14% |
| FY2024 | 14% |
| FY2025 | 14% |
Details›
- Gross margin12 months to Sep 30, 2026
- 33%
- Operating margin12 months to Sep 30, 2026
- 15%
- Net margin12 months to Sep 30, 2026
- 9.5%
- Free cash flow margin
- 12%
- Revenue, trailing twelve months
- $11.8B
- Free cash flow, trailing twelve months
- $1.38B
- Net income, trailing twelve months
- $1.13B
- Return on invested capitaloperating profit after tax ÷ debt + equity − cash
- 11%
Margins, capital and share counts from the statements as filed with the SEC; cash conversion is operating cash flow over operating profit after tax.
Diagnostics & Research
The closest names by size in the same industry